Anthony El-khoueiry is sharing the latest data from botensilimab/balstilimab in HCC at AACR 25 – Agenus Agenus shared on LinkedIn: “The Agenus team is live at AACR 25, where Dr. Anthony El-khoueiry is sharing the latest data from botensilimab/balstilimab in treatment-refractory hepatocellular carcinoma (HCC). Read more.” Read more about AACR 25 on OncoDaily. Blog Posts Agenus Anthony El-Khoueiry cancer HCC OncoDaily Oncology
